Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study

Purpose To evaluate the incidence of fragility fractures associated with high-dose glucocorticoid therapy in patients with systemic rheumatic disease. Methods: A retrospective study of patients who were treated with high-dose prednisolone (>0.8 mg/kg) for systemic rheumatic disease at Kobe Univer...

Full description

Bibliographic Details
Main Authors: Goichi Kageyama, Takaichi Okano, Yuzuru Yamamoto, Keisuke Nishimura, Daisuke Sugiyama, Jun Saegusa, Goh Tsuji, Shunichi Kumagai, Akio Morinobu
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Bone Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187216300511
_version_ 1831738916081762304
author Goichi Kageyama
Takaichi Okano
Yuzuru Yamamoto
Keisuke Nishimura
Daisuke Sugiyama
Jun Saegusa
Goh Tsuji
Shunichi Kumagai
Akio Morinobu
author_facet Goichi Kageyama
Takaichi Okano
Yuzuru Yamamoto
Keisuke Nishimura
Daisuke Sugiyama
Jun Saegusa
Goh Tsuji
Shunichi Kumagai
Akio Morinobu
author_sort Goichi Kageyama
collection DOAJ
description Purpose To evaluate the incidence of fragility fractures associated with high-dose glucocorticoid therapy in patients with systemic rheumatic disease. Methods: A retrospective study of patients who were treated with high-dose prednisolone (>0.8 mg/kg) for systemic rheumatic disease at Kobe University Hospital from April 1988 to March 2012. The primary outcome was a major osteoporotic fracture (defined as a clinical vertebral, hip, forearm, or proximal humerus fracture) after high-dose glucocorticoid therapy. For postmenopausal women and men over 40 of age, the patient's fracture risk at the beginning of high-dose glucocorticoid therapy was assessed by the World Health Organization's Fracture Risk Assessment Tool (FRAX®). Results Of 229 patients (median age: 49 years), 57 suffered a fragility fracture during the observation period (median observation period: 1558 days). Of 84 premenopausal patients, 5 suffered a fracture. In contrast, of 86 postmenopausal female, 36 suffered a fracture. Fragility fractures were far more frequent than predicted by the FRAX® score. Patients with FRAX® scores over 8.3% had a particularly high risk of fracture. Conclusions Fragility fractures associated with high-dose glucocorticoid therapy are common among postmenopausal women. Extreme care should be taken especially for postmenopausal women when high-dose glucocorticoid therapy is required.
first_indexed 2024-12-21T13:30:43Z
format Article
id doaj.art-2deec72ec5f54383a2544a2d16bcc2e8
institution Directory Open Access Journal
issn 2352-1872
language English
last_indexed 2024-12-21T13:30:43Z
publishDate 2017-06-01
publisher Elsevier
record_format Article
series Bone Reports
spelling doaj.art-2deec72ec5f54383a2544a2d16bcc2e82022-12-21T19:02:19ZengElsevierBone Reports2352-18722017-06-016C3810.1016/j.bonr.2016.11.003Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective studyGoichi Kageyama0Takaichi Okano1Yuzuru Yamamoto2Keisuke Nishimura3Daisuke Sugiyama4Jun Saegusa5Goh Tsuji6Shunichi Kumagai7Akio Morinobu8Department of Rheumatology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JapanDepartment of Rheumatology, Kobe University Hospital, Kobe, JapanDepartment of Rheumatology, Kobe University Hospital, Kobe, JapanDepartment of Rheumatology, Kobe University Hospital, Kobe, JapanDepartment of Preventive Medicine and Public Health, Keio University, Tokyo, JapanDepartment of Rheumatology, Kobe University Hospital, Kobe, JapanDepartment of Rheumatology, Shinko Hospital, Kobe, JapanDepartment of Rheumatology, Shinko Hospital, Kobe, JapanDepartment of Rheumatology, Kobe University Hospital, Kobe, JapanPurpose To evaluate the incidence of fragility fractures associated with high-dose glucocorticoid therapy in patients with systemic rheumatic disease. Methods: A retrospective study of patients who were treated with high-dose prednisolone (>0.8 mg/kg) for systemic rheumatic disease at Kobe University Hospital from April 1988 to March 2012. The primary outcome was a major osteoporotic fracture (defined as a clinical vertebral, hip, forearm, or proximal humerus fracture) after high-dose glucocorticoid therapy. For postmenopausal women and men over 40 of age, the patient's fracture risk at the beginning of high-dose glucocorticoid therapy was assessed by the World Health Organization's Fracture Risk Assessment Tool (FRAX®). Results Of 229 patients (median age: 49 years), 57 suffered a fragility fracture during the observation period (median observation period: 1558 days). Of 84 premenopausal patients, 5 suffered a fracture. In contrast, of 86 postmenopausal female, 36 suffered a fracture. Fragility fractures were far more frequent than predicted by the FRAX® score. Patients with FRAX® scores over 8.3% had a particularly high risk of fracture. Conclusions Fragility fractures associated with high-dose glucocorticoid therapy are common among postmenopausal women. Extreme care should be taken especially for postmenopausal women when high-dose glucocorticoid therapy is required.http://www.sciencedirect.com/science/article/pii/S2352187216300511Glucocorticoid induced osteoporosisFragility fractureFRAXHigh-dose glucocorticoid therapyAnd systemic rheumatic disease
spellingShingle Goichi Kageyama
Takaichi Okano
Yuzuru Yamamoto
Keisuke Nishimura
Daisuke Sugiyama
Jun Saegusa
Goh Tsuji
Shunichi Kumagai
Akio Morinobu
Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
Bone Reports
Glucocorticoid induced osteoporosis
Fragility fracture
FRAX
High-dose glucocorticoid therapy
And systemic rheumatic disease
title Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
title_full Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
title_fullStr Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
title_full_unstemmed Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
title_short Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study
title_sort very high frequency of fragility fractures associated with high dose glucocorticoids in postmenopausal women a retrospective study
topic Glucocorticoid induced osteoporosis
Fragility fracture
FRAX
High-dose glucocorticoid therapy
And systemic rheumatic disease
url http://www.sciencedirect.com/science/article/pii/S2352187216300511
work_keys_str_mv AT goichikageyama veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT takaichiokano veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT yuzuruyamamoto veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT keisukenishimura veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT daisukesugiyama veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT junsaegusa veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT gohtsuji veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT shunichikumagai veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy
AT akiomorinobu veryhighfrequencyoffragilityfracturesassociatedwithhighdoseglucocorticoidsinpostmenopausalwomenaretrospectivestudy